BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10837485)

  • 21. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization.
    Moen JL; Gorkun OV; Weisel JW; Lord ST
    Blood; 2003 Oct; 102(7):2466-71. PubMed ID: 12805063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR; Prchal JT; Mosesson MW
    Blood; 1988 Mar; 71(3):613-8. PubMed ID: 3345340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
    Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.
    Lewis SD; Shields PP; Shafer JA
    J Biol Chem; 1985 Aug; 260(18):10192-9. PubMed ID: 4019507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The release of small amounts of fibrinopeptide-B (FPB) is of critical importance for the thrombin clotting time.
    Holm B; Kierulf P; Godal HC
    Thromb Res; 1986 May; 42(4):517-26. PubMed ID: 3715815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight from studies with recombinant fibrinogens.
    Lord ST; Gorkun OV
    Ann N Y Acad Sci; 2001; 936():101-16. PubMed ID: 11460465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
    Lord ST; Strickland E; Jayjock E
    Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
    Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
    Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.
    Gorkun OV; Veklich YI; Weisel JW; Lord ST
    Blood; 1997 Jun; 89(12):4407-14. PubMed ID: 9192765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.
    Okumura N; Gorkun OV; Terasawa F; Lord ST
    Blood; 2004 Jun; 103(11):4157-63. PubMed ID: 14764520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
    Mullin JL; Gorkun OV; Lord ST
    Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.
    Lewis SD; Lorand L; Fenton JW; Shafer JA
    Biochemistry; 1987 Dec; 26(24):7597-603. PubMed ID: 3427095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.